Inhaled Drug Delivery: Devices, Indications, Therapeutics, Markets and Forecasts

Inhaled Drug Delivery: Devices, Indications, Therapeutics, Markets and Forecasts

NEW YORK, Jan. 19, 2012  /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Inhaled Drug Delivery: Devices, Indications, Therapeutics, Markets and Forecasts

http://www.reportlinker.com/p0761241/Inhaled-Drug-Delivery-Devices-Indications-Therapeutics-Markets-and-Forecasts.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

Advances in drug formulation and inhalation device design are creating new opportunities for inhaled drug delivery as an alternative to oral and parenteral delivery methods. Nebulizers, metered dose inhalers (MDIs), and dry powder inhalers (DPIs) have each found a niche in the quest for optimal treatment and convenient use. While nebulizers have evolved relatively independently of the drug formulations they deliver, the current generation of MDIs and DPIs have been developed or tailored for the specific pharmaceutical being delivered, resulting in improved performance. Several of the emerging drug products covered in this report will have a significant impact in the therapeutic markets they target, improving patient compliance and effectively changing the way important illnesses and conditions are treated.

Highlights • Analyzes and evaluates inhaled drugs currently in development and assesses the market potential for existing and probable future products

• Examines inhalation device technology for commercial and development-stage devices, and evaluates product technology issues and evolving market factors

• Provides detailed assessments of targeted disease segments, forecast growth and market potential, and therapeutic options

• Forecasts the impact of new and emerging inhaled drug therapeutics on healthcare markets and prescribing decisions to 2016

Executive Summary Inhaled Drug Market Dynamics

Therapeutic TargetsDemographics and GrowthCompeting TechnologiesMarket DriversFactors Limiting Growth

Inhalation Technology & Product

Development Factors

Drug FormulationsFormulation TechnologiesExcipients and Release ProfilesInhalation Device Design FactorsDry Powder InhalersMetered Dose InhalersNebulizersPerformance FactorsBioavailabilityDose ReproducibilityActive Compound StabilityCombination Drug InhalersTesting and PackagingEmerging Device Technologies

Inhalation Devices – Device

Assessments and Product Strategies

Dry Powder inhalers

Commercial Devices

Development-stage DPI Devices

Metered Dose Inhalers

Nebulizers

Compressed Air Nebulizers

Ultrasonic Nebulizers

Advanced Technology Nebulizers

Inhaled Drugs – Therapeutic SegmentAnalysis & ForecastsUpper Respiratory IndicationsAsthma/COPDAllergic Rhinitis

Systemic Drug Delivery

Anaphylaxis

Bioterror

Cardiovascular Medicine

Diabetes

Hereditary Diseases

Immunology

Infectious Diseases

Osteoporosis

Neurology

Oncology

Pain Management

Sexual Health

Market FactorsDevice PackagingRegulatory IssuesPatient ComplianceThe Role of CMOs/CSOsHealthcare Economics

Market Sector Company Profiles

To order this report: Drug Delivery Technology Industry: Inhaled Drug Delivery: Devices, Indications, Therapeutics, Markets and Forecasts

More  Market Research Report

Check our  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

Back to top

RELATED LINKS
http://www.reportlinker.com

Source: www.prnewswire.com